Company / Net Debt per Share
Cytokinetics Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$1031.33
FY2025
5-year range
-$0.77 / $1031.33
FY2021-FY2025
Trend
+19879.0%
vs FY2024
Sector context
#1 of 82
Health Care
What the data says
Net Debt per Share changed +19879% YoY in FY2025, a notable deviation from the 9-year average annual change of +2814%.
Based on SEC 10-K filings.
1031.33 in FY2025 with a 3-year CAGR of +431.0%. Ranks 1st among 82 companies in Health Care.
Increased from $5.55 to $1031.33 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- +431.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 82This company $1031.33 Sector average $13.70
▼
+7429.5% above sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 19879.0% year-over-year.
- Ranks #1 out of 82 companies in the Health Care sector.
- Lowest net debt per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1031.33 | +19879.0% |
| FY2024 | $5.16 | -7.0% |
| FY2023 | $5.55 | -19.4% |
| FY2022 | $6.89 | +994.3% |
| FY2021 | -$0.77 | -48.7% |
| FY2020 | -$0.52 | -455.5% |
| FY2019 | $0.15 | +4976.6% |
| FY2018 | $0.00 | +100.2% |
| FY2017 | -$1.73 | -90.2% |
| FY2016 | -$0.91 | +28.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026